Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Ethiopian Public Health Association, Addis Ababa, Ethiopia.
Pan Afr Med J. 2020 Oct 20;37:171. doi: 10.11604/pamj.2020.37.171.23543. eCollection 2020.
measles is the leading vaccine preventable childhood disease designated for elimination by WHO. More than 20 million people are affected by measles each year, particularly in Africa and Asia. With annual outbreaks reported from Ethiopia´s Oromia region. We analyzed measles containing vaccine coverage (MCV), measles cases and measles deaths over a 10-year period (2007-2016).
we reviewed Oromia measles surveillance data and first-dose measles containing vaccine (MCV1) administrative coverage. Descriptive statistics and multivariable logistic regression were performed to assess variables associated with measles death. Additional spatial mapping was performed to visually display key areas of measles case distribution in Oromia.
a total of 26,908 measles suspect cases were identified, of which 18,223 (68%) were confirmed. A median age of 6 years (IQ range 0.5-71 years) and 288 deaths were observed. Among the total cases, 29% were unvaccinated and 46% had unknown vaccination status. The highest IR was seen in Guji zone (IR=190/100,000 population) among 1-4 years, with a majority from rural areas. Risk factors associated with death include age <5 years (AOR=1.82, CI: 1.42-2.33), unvaccinated status (AOR=1.44, CI: 1.06-1.95) and inpatient treatment (AOR=2.12, CI: 1.58-2.85). Of 8,732 measles IgM negative/indeterminate specimens, 10.5% tested positive for rubella specific IgM.
outbreaks of measles are an ongoing public health concern in the Oromia region. Children aged 1-15 years remain at high risk for contracting measles in the region. We recommend strengthening routine immunization to reach all children, especially in rural areas and that the measles-rubella (MR) vaccine be considered.
麻疹是世界卫生组织(WHO)指定消除的主要疫苗可预防儿童疾病。每年有超过 2000 万人感染麻疹,特别是在非洲和亚洲。埃塞俄比亚奥罗米亚地区每年都有麻疹爆发报告。我们分析了奥罗米亚地区 10 年来(2007-2016 年)的麻疹疫苗覆盖率(MCV)、麻疹病例和麻疹死亡情况。
我们回顾了奥罗米亚麻疹监测数据和第一剂含麻疹疫苗(MCV1)的行政覆盖率。采用描述性统计和多变量逻辑回归分析评估与麻疹死亡相关的变量。还进行了额外的空间映射,以直观显示奥罗米亚麻疹病例分布的关键区域。
共发现 26908 例麻疹疑似病例,其中 18223 例(68%)确诊。中位年龄为 6 岁(0.5-71 岁 IQ 范围),死亡 288 例。在所有病例中,29%未接种疫苗,46%疫苗接种状况不明。在古吉地区(1-4 岁人群的发病率为 190/100000 人),发病率最高,且大多数病例来自农村地区。与死亡相关的风险因素包括年龄<5 岁(AOR=1.82,CI:1.42-2.33)、未接种疫苗(AOR=1.44,CI:1.06-1.95)和住院治疗(AOR=2.12,CI:1.58-2.85)。在 8732 例麻疹 IgM 阴性/不确定标本中,10.5%的风疹特异性 IgM 检测呈阳性。
麻疹疫情是奥罗米亚地区持续存在的公共卫生问题。该地区 1-15 岁儿童仍面临感染麻疹的高风险。我们建议加强常规免疫接种,以覆盖所有儿童,特别是农村地区,并考虑使用麻疹-风疹(MR)疫苗。